{{Drugbox
| IUPAC_name = (''RS'')-1-[2-[(2,6-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1''H''-imidazole
| image = Isoconazole.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|isoconazole}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 27523-40-6
| ATC_prefix = D01
| ATC_suffix = AC05
| ATC_supplemental =   {{ATC|G01|AF07}}
| PubChem = 3760
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08943
| ChEMBL = 1571863
| ChemSpiderID = 3629
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = GRI7WFR424
| KEGG = D04624
| ChEBI_Ref = {{ebicite|correct|EBI}} 
| ChEBI = 82865

<!--Chemical data-->
| C=18 | H=14 | Cl=4 | N=2 | O=1 
| molecular_weight = 416.127 g/mol
| smiles = Clc1ccc(c(Cl)c1)C(OCc2c(Cl)cccc2Cl)Cn3ccnc3
}}

'''Isoconazole''' is an [[azole]] [[antifungal drug]] and could inhibit gram positive bacteria.<ref name=":0">{{Cite journal|title = Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids|journal = Mycoses|date = May 2013|issn = 1439-0507|pmid = 23574019|pages = 3–15|volume = 56 Suppl 1|doi = 10.1111/myc.12054|first = Stefano|last = Veraldi}}</ref><ref>''[[The Merck Index]]'', 12th Edition, '''5176'''</ref> [[Nigeria]]n and [[Great Britain|British]] medical researchers found that for foot and vaginal infections, isoconazole has a similar effectiveness to [[clotrimazole]].<ref name="uniNigeria_isoconazole">{{cite journal| last =Oyeka| first =C.A.| authorlink =|author2=Gugnani H.C.| title =Isoconazole nitrate versus clotrimazole in foot and nail infections due to Hendersonula toruloidea, Scytalidium hyalinum and dermatophytes.| work =| publisher =| year =1992| pmid =1302811 | doi =10.1111/j.1439-0507.1992.tb00894.x| volume=35| issue=11-12| journal=Mycoses| pages=357–61}}</ref><ref name="Brit_isoconazole">{{cite web| last =Cohen| first =L.| authorlink =| title =Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole.| work =| publisher =| year =1984| url = http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1046268| doi =| accessdate =2008-05-23 }}</ref> Isoconazole nitrate may be used in combination with [[corticosteroid]] [[diflucortolone]] to increase its [[bioavailability]].<ref name=":0" />

==References==
{{Reflist|2}}

{{Antifungals}}
{{Gynecological anti-infectives and antiseptics}}

[[Category:21-Hydroxylase inhibitors]]
[[Category:Aromatase inhibitors]]
[[Category:Chloroarenes]]
[[Category:CYP17A1 inhibitors]]
[[Category:Ethers]]
[[Category:Imidazole antifungals]]
[[Category:Lanosterol 14α-demethylase inhibitors]]


{{dermatologic-drug-stub}}
{{genito-urinary-drug-stub}}